Physician profile
Matthew E Weber
NPI 1033186895
$870.14
in general payments reported to CMS, 2019-2025
11 companies · $424 in 2025
The $424 reported for 2025 was more than what 91% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $56.06 · 2023: $20.13 · 2024: $157 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $600.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $272.42 | 2024-2025 | Novosorb Btm |
| Becton, Dickinson and Company | $177.31 | 2025 | Arista |
| Zimmer Biomet Holdings, INC. | $131.11 | 2025 | Sternalock |
| Genentech USA, INC. | $52.87 | 2019-2020 | |
| Kaleo, INC. | $51.60 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $50.43 | 2019 | |
| Shire North American Group INC | $30.99 | 2019 | |
| Cranial Technologies, INC | $29.60 | 2019-2020 | |
| Tris Pharma INC | $27.37 | 2019 | |
| Pfizer INC. | $26.31 | 2019 | |
| Depuy Synthes Sales INC. | $20.13 | 2023 | Attune, Actis, Kincise |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.